Literature DB >> 21414908

Protein misfolding and oxidative stress promote glial-mediated neurodegeneration in an Alexander disease model.

Liqun Wang1, Kenneth J Colodner, Mel B Feany.   

Abstract

Although alterations in glial structure and function commonly accompany death of neurons in neurodegenerative diseases, the role glia play in modulating neuronal loss is poorly understood. We have created a model of Alexander disease in Drosophila by expressing disease-linked mutant versions of glial fibrillary acidic protein (GFAP) in fly glia. We find aggregation of mutant human GFAP into inclusions bearing the hallmarks of authentic Rosenthal fibers. We also observe significant toxicity of mutant human GFAP to glia, which is mediated by protein aggregation and oxidative stress. Both protein aggregation and oxidative stress contribute to activation of a robust autophagic response in glia. Toxicity of mutant GFAP to glial cells induces a non-cell-autonomous stress response and subsequent apoptosis in neurons, which is dependent on glial glutamate transport. Our findings thus establish a simple genetic model of Alexander disease and further identify cellular pathways critical for glial-induced neurodegeneration.

Entities:  

Mesh:

Year:  2011        PMID: 21414908      PMCID: PMC3082397          DOI: 10.1523/JNEUROSCI.3410-10.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  44 in total

1.  Conversion of lacZ enhancer trap lines to GAL4 lines using targeted transposition in Drosophila melanogaster.

Authors:  K J Sepp; V J Auld
Journal:  Genetics       Date:  1999-03       Impact factor: 4.562

2.  Targeted deletion in astrocyte intermediate filament (Gfap) alters neuronal physiology.

Authors:  M A McCall; R G Gregg; R R Behringer; M Brenner; C L Delaney; E J Galbreath; C L Zhang; R A Pearce; S Y Chiu; A Messing
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

3.  Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice.

Authors:  A Messing; M W Head; K Galles; E J Galbreath; J E Goldman; M Brenner
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

4.  GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination.

Authors:  W Liedtke; W Edelmann; P L Bieri; F C Chiu; N J Cowan; R Kucherlapati; C S Raine
Journal:  Neuron       Date:  1996-10       Impact factor: 17.173

5.  Drosophila mutants with opposing effects on nerve excitability: genetic and spatial interactions in repetitive firing.

Authors:  B Ganetzky; C F Wu
Journal:  J Neurophysiol       Date:  1982-03       Impact factor: 2.714

6.  puckered encodes a phosphatase that mediates a feedback loop regulating JNK activity during dorsal closure in Drosophila.

Authors:  E Martín-Blanco; A Gampel; J Ring; K Virdee; N Kirov; A M Tolkovsky; A Martinez-Arias
Journal:  Genes Dev       Date:  1998-02-15       Impact factor: 11.361

7.  Rosenthal fibers share epitopes with alpha B-crystallin, glial fibrillary acidic protein, and ubiquitin, but not with vimentin. Immunoelectron microscopy with colloidal gold.

Authors:  N Tomokane; T Iwaki; J Tateishi; A Iwaki; J E Goldman
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

8.  Deficient cerebellar long-term depression, impaired eyeblink conditioning, and normal motor coordination in GFAP mutant mice.

Authors:  K Shibuki; H Gomi; L Chen; S Bao; J J Kim; H Wakatsuki; T Fujisaki; K Fujimoto; A Katoh; T Ikeda; C Chen; R F Thompson; S Itohara
Journal:  Neuron       Date:  1996-03       Impact factor: 17.173

9.  Identification and characterization of a cDNA encoding a neuronal glutamate transporter from Drosophila melanogaster.

Authors:  R P Seal; G M Daniels; W J Wolfgang; M A Forte; S G Amara
Journal:  Receptors Channels       Date:  1998

10.  Mice lacking glial fibrillary acidic protein display astrocytes devoid of intermediate filaments but develop and reproduce normally.

Authors:  M Pekny; P Levéen; M Pekna; C Eliasson; C H Berthold; B Westermark; C Betsholtz
Journal:  EMBO J       Date:  1995-04-18       Impact factor: 11.598

View more
  34 in total

1.  Alexander disease causing mutations in the C-terminal domain of GFAP are deleterious both to assembly and network formation with the potential to both activate caspase 3 and decrease cell viability.

Authors:  Yi-Song Chen; Suh-Ciuan Lim; Mei-Hsuan Chen; Roy A Quinlan; Ming-Der Perng
Journal:  Exp Cell Res       Date:  2011-07-02       Impact factor: 3.905

2.  Glial α-synuclein promotes neurodegeneration characterized by a distinct transcriptional program in vivo.

Authors:  Abby L Olsen; Mel B Feany
Journal:  Glia       Date:  2019-07-03       Impact factor: 7.452

3.  Effects of traumatic brain injury on reactive astrogliosis and seizures in mouse models of Alexander disease.

Authors:  Maria Luisa Cotrina; Michael Chen; Xiaoning Han; Jeffrey Iliff; Zeguang Ren; Wei Sun; Tracy Hagemann; James Goldman; Albee Messing; Maiken Nedergaard
Journal:  Brain Res       Date:  2014-07-25       Impact factor: 3.252

4.  Glutathionylation primes soluble glyceraldehyde-3-phosphate dehydrogenase for late collapse into insoluble aggregates.

Authors:  Mirko Zaffagnini; Christophe H Marchand; Marco Malferrari; Samuel Murail; Sara Bonacchi; Damiano Genovese; Marco Montalti; Giovanni Venturoli; Giuseppe Falini; Marc Baaden; Stéphane D Lemaire; Simona Fermani; Paolo Trost
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-26       Impact factor: 11.205

5.  Relative stabilities of wild-type and mutant glial fibrillary acidic protein in patients with Alexander disease.

Authors:  Michael R Heaven; Landon Wilson; Stephen Barnes; Michael Brenner
Journal:  J Biol Chem       Date:  2019-09-04       Impact factor: 5.157

Review 6.  Drug screening in Drosophila; why, when, and when not?

Authors:  Tin Tin Su
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2019-05-05       Impact factor: 5.814

7.  Nigella sativa Oil Reduces Extrapyramidal Symptoms (EPS)-Like Behavior in Haloperidol-Treated Rats.

Authors:  Tafheem Malik; Sheema Hasan; Shahid Pervez; Tasneem Fatima; Darakhshan Jabeen Haleem
Journal:  Neurochem Res       Date:  2016-10-18       Impact factor: 3.996

8.  GFAP Mutations in Astrocytes Impair Oligodendrocyte Progenitor Proliferation and Myelination in an hiPSC Model of Alexander Disease.

Authors:  Li Li; E Tian; Xianwei Chen; Jianfei Chao; Jeremy Klein; Qiuhao Qu; Guihua Sun; Guoqiang Sun; Yanzhou Huang; Charles D Warden; Peng Ye; Lizhao Feng; Xinqiang Li; Qi Cui; Abdullah Sultan; Panagiotis Douvaras; Valentina Fossati; Neville E Sanjana; Arthur D Riggs; Yanhong Shi
Journal:  Cell Stem Cell       Date:  2018-08-02       Impact factor: 24.633

9.  Astrocytic TDP-43 pathology in Alexander disease.

Authors:  Adam K Walker; Christine M LaPash Daniels; James E Goldman; John Q Trojanowski; Virginia M-Y Lee; Albee Messing
Journal:  J Neurosci       Date:  2014-05-07       Impact factor: 6.167

10.  Early mitochondrial dysfunction leads to altered redox chemistry underlying pathogenesis of TPI deficiency.

Authors:  Stacy L Hrizo; Isaac J Fisher; Daniel R Long; Joshua A Hutton; Zhaohui Liu; Michael J Palladino
Journal:  Neurobiol Dis       Date:  2013-01-12       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.